On August 10, 2026, South Korea’s domestic pharmaceutical and biotech equities surged, bolstered by a technical rebound in the Kosdaq index. FromBio (KOSDAQ: 377220) hit the daily ceiling price immediately … Read More
A sweeping epidemiological study mapping birth order and disease risk across 10 million sibling pairs reveals distinct patterns in pediatric and adult health outcomes. Led by researchers examining massive population … Read More
Orient Bio has announced preclinical developments for its proprietary hair growth candidate, OND-1, which demonstrated regenerative efficacy up to ten times stronger than standard topical minoxidil in preliminary laboratory assessments. … Read More
The 2026 Medical Training Survey (MTS) officially opened across Australia, inviting medical trainees to share confidential feedback about their workplace experiences. Led by the Australian Health Practitioner Regulation Agency (Ahpra) … Read More
Over the past fifty years, average testosterone levels in men have declined by more than 50%, a trend observed. This significant shift in endocrine health is linked to complex environmental, … Read More
As of June 2026, the U.S. Food and Drug Administration (FDA) continues to report significant supply chain disruptions for methylphenidate—the active ingredient in Ritalin—and various amphetamine-based stimulants. With Oryza Pharmaceuticals … Read More
Following a recent study from University College London, clinicians are being urged to exercise greater vigilance when prescribing gabapentinoids such as gabapentin and pregabalin for chronic pain, due to emerging … Read More
“`html Pharmacists’ Expanded Roles Dramatically Improve Patient Outcomes, New Study Reveals Table of Contents 1. Pharmacists’ Expanded Roles Dramatically Improve Patient Outcomes, New Study Reveals 2. The Impact of pharmacist … Read More
Breaking: Legislation Faces Slim Senate Odds as House Action Sparks bipartisan Talks Table of Contents 1. Breaking: Legislation Faces Slim Senate Odds as House Action Sparks bipartisan Talks 2. What … Read More
Breaking: Nine Pharma Giants Agree To Cut Prices For Medicaid And Cash-Paying Patients Table of Contents 1. Breaking: Nine Pharma Giants Agree To Cut Prices For Medicaid And Cash-Paying Patients … Read More
